Home > Bulk & Specialty Chemicals > Biocatalyst Market
Biocatalyst Market Size, By Source (Animal, Plants, Microorganisms), By Type (Hydrolases, Oxidoreductases, Transferases), By Application (F&B Industry, Cleaning Agents, Biofuel Production, Agriculture & Feed, Biopharmaceuticals), Market Forecast, 2023 - 2032
- Report ID: GMI5490
- Published Date: Mar 2023
- Report Format: PDF
Industry Statistics
Biocatalyst Market size attained a valuation of over USD 500 million in 2022 and is estimated to exhibit above 6% CAGR from 2023 to 2032 owing to the increasing demand for biocatalysts from the biopharmaceutical industry in manufacturing active pharmaceutical ingredients (API).
Get more details on this report - Request Free Sample PDF
The pharmaceutical sector has crossed leaps and bounds in recent years, given the escalating drug development projects and the growing prevalence of chronic and infectious diseases in people of all age groups.
Based on the Indian Economic Survey 2021, the pharmaceutical market in India stood at US$ 42 billion in 2021 and is predicted to register a three-fold growth by 2030, reaching US$ 120-130 billion by 2030. Since bio catalysis is extensively utilized across the pharmaceutical industry to catalyze chemical transformations to suffice the increasing requirements for a growing number of reactions during drug development.
| Report Coverage | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 520 Million |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 6.4 % |
| 2032 Value Projection: | USD 950 Million |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 172 |
| Tables, Charts & Figures: | 257 |
| Segments covered: | Source, Application, Type, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Get more details on this report - Request Free Sample PDF
However, the lack of adequate regulations pertaining to the use of other competing technologies and applications may hamper market performance. In addition, limited consumer awareness about biocatalysts may challenge industry progression. In contrast, rising environmental concerns and the increasing penetration of biocatalysts across several industry verticals will favor market progress.
Hydrolases to witness increased growth due to their expansive application spectrum
Get more details on this report - Request Free Sample PDF
Based on type, the overall market size is fragmented into Hydrolases, Oxidoreductases, Transferases, and Others comprising Lysase, Isomerases, and Ligases. The hydrolases segment of the biocatalyst market is slated to be worth USD 430 million by 2032, given the increasing usage of hydrolases in a range of cleansing agents, Food & Beverages, and biofuel production. Besides, the ease of use, broad range availability and high compatibility of hydrolases with organic solvents are some other factors fostering product adoption.
Escalating R&D projects to boost the demand for microbial-catalyzed bioenzymes
| Application | Market Share in 2022 |
|---|---|
| Plants | 26.2% |
| Animals | 28.73% |
| Microorganisms | 45.07% |
| Total | 100.0% |
Get more details on this report - Request Free Sample PDF
Regarding the source, the biocatalyst market share is classified into Plants, Animals, and Microorganisms. The microorganisms segment is set to expand at over 6% CAGR between 2023 and 2032, attributed to the easy, consistent, and cost-effective production of biocatalysts through microorganisms. Microbial-catalyzed biotransformations retain substantial potential in generating a variety of structurally diversified organic compounds, specifically natural products with intricate structures such as flavonoids, triterpenoids, steroids, sesquiterpenoids, and steroidal saponins. Consistent R&D efforts toward obtaining biologically active molecules with myriad structural features will drive segment share.
Extensive product usage in biopharmaceutical applications to aid industry growth
Get more details on this report - Request Free Sample PDF
Biocatalysts find extensive applications in food and beverages, cleaning agents, biofuel production, agriculture and feed, biopharmaceuticals, and others. The industry revenue from the biopharmaceuticals segment is anticipated to grow at 7% CAGR from 2023 to 2032, owing to the growing usage of biocatalysts resulting in high-quality biopharmaceutical ingredients like proteins, nucleic acids, etc. Additionally, the increasing R&D investments on several drug development projects will further aid segment size.
Improving technological outlook to drive product demand across Europe
Get more details on this report - Request Free Sample PDF
Geographically, the Europe biocatalyst market is expected to garner USD 280 million in revenues by 2032. Europe is one of the leading pharmaceutical manufacturers globally. In 2020, the region invested an estimated € 39,000 million in R&D, as per the European Federation of Pharmaceutical Industries and Associations. High research and development activities due to advanced technological innovation in the biocatalyst domain is another crucial factor positively impacting the market trends.
Novel innovations to define the competitive landscape
Leading companies constituting the competitive landscape of the biocatalyst market are BASF SE, Novozymes, DuPont, Codexis, Inc., Biocatalysts Limited, AB Enzymes, Prozomix Limited, Royal DSM, Lonza, Amano Enzyme Inc., Biosyntha Technology Ltd, and others.
Participatory firms in this business have been focusing on developing cutting-edge innovations to gain a strong foothold globally. For instance, in July 2022, LanzaTech, an innovative Chicago-based Carbon Capture and Transformation (“CCT”) firm that converts waste carbon into sustainable materials such as fuels, packaging, fabrics, and other products, unveiled that it has successfully developed specialized biocatalysts to produce ethylene directly from CO2 in a steady process.
Impact of the COVID-19 pandemic on the biocatalyst market trends
During the Covid-19 pandemic, pharmaceutical products witnessed the highest demand, and the demand for new drugs is still on the rise, given the recurrence of new COVID-19 variants in various countries. This apart, food & beverage sales registered a record growth during the crisis due to stockpiling buyer behavior and increasing panic buying. With the demand for new drugs and preventive therapies continues to rise across both developed and developing economies, attributed to the growing prevalence of lifestyle diseases and aging population, the biocatalyst industry size will grow considerably over the coming years.
The Biocatalyst market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilo Tons and revenue in USD Million from 2018 to 2032 for the following segments:
By Sources
- Plants
- Animals
- Microorganisms
By Type
- Hydrolases
- Oxidoreductases
- Transferases
- Others
By Application,
- Food and Beverage Industry
- Cleaning Agents
- Biofuel Production
- Agriculture and Feed
- Biopharmaceuticals
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Asia Pacific
- China
- India
- Japan
- Indonesia
- South Korea
- Malaysia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- UAE
- South Africa
- Saudi Arabia